24 / 30
Sensor100
July 2015
24
Healthcare
Gentag, Mayo Clinic, NovioSense and Fraunhofer Join
Forces to Lower the Cost of Diabetes Care Globally
Building on the long-standing collaboration between Gentag and Mayo
Clinic, and the long-standing collaboration between NovioSense and
Fraunhofer Institute for Microelectronic Circuits and Systems (IMS),
Gentag and NovioSense today announced that they have formed a joint
venture to combat the epidemic of type 2 diabetes that is overwhelm-
ing people and health care systems worldwide.The venture projects:
Exciting, new, patented technology platform poised
to disrupt diabetes care delivery globally
Extremely low-cost, pain-free system could be a
game changer
No more lancets, glucometers
Real-time cloud-based readings deliverable to car-
egivers and providers anywhere instantly via NFC
cell phones
Opportunity to improve diabetes outcomes world-
wide
Using their patented combined assets that include advanced chemistry
knowledge, proprietary sensor designs, and software and chip (ASIC)
design capabilities, the four parties will combine forces to develop a
mobile-phone based platform to bring very low-cost, on-demand pain
free diabetes monitoring to people worldwide. The joint venture is
covered by 75 issued patents worldwide and is significantly lower cost
than current type 2 diabetes solutions. Development will be carried out
simultaneously on both sides of the Atlantic.
Reported by:
BusinessWire ,July 14, 2015